00:00
Money for You
Money for You
USD/RUB
EUR/RUB
Market Quotes

Icon Shares Sink 30% as Accounting Probe Delays Financial Reports

Clinical research giant Icon plc has postponed its fourth-quarter earnings and withdrawn its 2025 guidance following the launch of an internal review into its accounting controls. The investigation, which focuses on revenue recognition over the past two years, triggered a massive premarket sell-off on Thursday.

Icon Shares Sink 30% as Accounting Probe Delays Financial Reports

Revenue Recognition Under Scrutiny

The board’s audit committee initiated the probe in October after management raised concerns regarding internal financial reporting. Supported by outside legal counsel and forensic accounting firms, the review aims to determine if the company’s top line was overstated in 2023 and 2024. Preliminary findings suggest that revenue for those years may have been inflated by less than 2% annually.

The news sent Icon shares tumbling 30% to $93 in premarket trading, extending a downward trend that has seen the stock lose a quarter of its value over the past year. In response to the ongoing investigation, the company has pushed its fourth-quarter and full-year 2025 reporting deadline to April 30 and scrapped its previously issued financial targets for the year.

Despite the accounting discrepancies, the company maintains that the issues are internal and have not affected its service delivery. Board Chair Ciaran Murray expressed confidence in the current executive team, noting that the board is committed to implementing necessary changes to governance and oversight. Icon stated it has not identified any impact on its customers resulting from the practices currently under review.

Share

Comments (0)

Leave a comment

No comments yet. Be the first!